Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Circulation|August 1, 1988
Changes in spontaneous variability of ventricular ectopic activity as a function of time in patients with chronic arrhythmiasM I Anastasiou-Nana, R L Menlove, J N Nanas, et al.
American Heart Journal|November 1, 1986
HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factorsM I Anastasiou-Nana, J L Anderson, J F Carlquist, et al.
Chest|June 1, 1995
Effect of acute allograft rejection on exercise hemodynamics in patients who have undergone cardiac transplantationJ N Nanas, M I Anastasiou-Nana, R B Sutton, et al.
American Heart Journal|October 1, 1991
Spontaneous variability of ventricular arrhythmias in patients with chronic heart failureM I Anastasiou-Nana, R L Menlove, J N Nanas, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 1, 1997
Redistribution of amiodarone in heart transplant recipients treated with the drug before operationJ N Nanas, M I Anastasiou-Nana, Z J Margari, et al.
The Canadian Journal of Cardiology|July 1, 1986
Comparison of Fick and dye cardiac outputs during rest and exercise in 1,022 patientsJ N Nanas, M I Anastasiou-Nana, R B Sutton, et al.
Journal of the American College of Cardiology|August 1, 1986
Recainam, a potent new antiarrhythmic agent: effects on complex ventricular arrhythmiasM I Anastasiou-Nana, J L Anderson, E M Hampton, et al.
Cardiovascular Drugs and Therapy|October 24, 2001
Intravenous amiodarone decreases the duration of atrial fibrillation associated with acute myocardial infarctionD A Kontoyannis, M I Anastasiou-Nana, S A Kontoyannis, et al.
Catheterization and Cardiovascular Diagnosis|September 1, 1989
Relative efficiency and risk of endomyocardial biopsy: comparisons in heart transplant and nontransplant patientsM I Anastasiou-Nana, J B O'Connell, J N Nanas, et al.
American Heart Journal|December 1, 1985
Initial and long-term outpatient experience with lorcainide for suppression of malignant and potentially malignant ventricular arrhythmiasM I Anastasiou-Nana, J L Anderson, E M Hampton, et al.
Pageof 3